Please login to the form below

Not currently logged in
Email:
Password:

PATH Malaria Vaccine Initiative

This page shows the latest PATH Malaria Vaccine Initiative news and features for those working in and with pharma, biotech and healthcare.

GSK hoping to file malaria vaccine next year

GSK hoping to file malaria vaccine next year

GSK hoping to file malaria vaccine next year. New phase III data backs submission plans. ... RTS, S is being developed by GSK and the PATH Malaria Vaccine Initiative (MVI), alongside African research centres, with funding support from the Bill &Melinda

Latest news

  • GSK's malaria vaccine effects 'modest' in infants GSK's malaria vaccine effects 'modest' in infants

    GSK's malaria vaccine effects 'modest' in infants. Less than expected efficacy findings surprise researchers. ... RTS, S is being developed by GSK and the PATH Malaria Vaccine Initiative (MVI), alongside African research centres, with funding support

  • European vaccines market set to double by 2018 European vaccines market set to double by 2018

    Noted recent successes in vaccination include the human papillomavirus (HPV) vaccine to protect people from cervical cancer. ... College, the PATH Malaria Vaccine Initiative (MVI) and the International AIDS Vaccine Initiative (IAVI) to identify vaccine

  • New malaria reference lab to help move vaccine candidates into trials

    PATH Malaria Vaccine Initiative collaborates with the International AIDS Vaccine Initiative and Imperial College London. ... The project will see Imperial work with the PATH Malaria Vaccine Initiative (MVI) and the International AIDS Vaccine Initiative

  • GSK success in malaria vaccine trial

    The vaccine is being developed in partnership by GSK and the PATH Malaria Vaccine Initiative (MVI), together with African research centres. ... Andrew Witty, CEO of GSK, commented that the results had brought the company "to the cusp" of the first

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics